XSWX: ALC
Last close prices updated as of
Jun 05, 2023, 5:31 PM CET
| CHF
- Last Close 72.10
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Investment Style Large Growth
- Day Range 71.82 – 72.68
- Year Range 55.24 – 74.88
- Market Cap 35.3604 Bil
- Volume / Avg 526,116.0 / 1.3 Mil
- Price / Sales 4.41
- Price / Book 1.98
- Forward Div Yield 0.29%
- Trailing Div Yield 0.29%
Morningstar‘s Stock Analysis ALC
Valuation
Currency in —
Is it the right time to buy or sell?
Is it the right time to buy or sell?
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
About Quantitative Ratings
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Unlock Our Full Analysis With Morningstar Investor
Company Profile ALC
Business Description
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of ALC’s competitive advantage.
Alcon Inc
XSWX: ALC
| The Cooper Companies Inc
XNYS: COO
| Carl Zeiss Meditec AG
XETR: AFX
| |
Price
| 71.90 | 355.77 | 110.35 |
Currency
| CHF | USD | EUR |
Change
| −$0.20 (0.28%) | −$0.71 (0.20%) | −$1.25 (1.12%) |
Market Cap
| 35.36 Bil | 17.58 Bil | 9.87 Bil |
Industry
| Medical Instruments & Supplies | Medical Instruments & Supplies | Medical Instruments & Supplies |
Sector
|
Healthcare
|
Healthcare
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Alcon Inc Stock
Yes. ALC has a forward dividend yield of 0.29%.
See
ALC’s full dividends and stock split history
on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
ALC’s market cap is 35.36 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
ALC’s stock style is Large Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
ALC’s price/sales is 4.20.
Price/sales represents the amount an investor is willing to pay for a dollar generated from
a particular company’s sales or revenues.
ALC’s price/forward earnings is 109.36.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates.
The lower the Forward P/E, the cheaper the stock.
ALC’s price/book is 1.94.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets,
based on historical, rather than current, valuations. Historical valuations generally do not reflect
a company’s current market value. Value investors frequently look for companies that have low price/book ratios.
See ALC’s valuation ratios compared to the Market Index.
ALC’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare ALC’s historical performance against its industry peers and the overall market.